Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer

Name: Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer
License: Public Domain

Roswell Park Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anatomic stage iv breast cancer ajcc v8, metastatic triple-negative breast carcinoma, unresectable triple-negative breast carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208449
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.